HANLIM PHARMACEUTICAL CO., LTD. Patent applications |
Patent application number | Title | Published |
20130252929 | PHARMACEUTICAL COMPOSITION INCLUDING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE FOR NASAL ADMINISTRATION - The present invention provides a pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride, wherein the pharmaceutical composition comprises thaumatin as an agent for reducing bitterness and irritation. | 09-26-2013 |
20120172394 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS, CONTAINING REBAMIPIDE - The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg. | 07-05-2012 |